Pneumocystis Jirovecii Pneumonia in COVID-19: an Overlooked Clinical Entity-Response to "Pneumocystis Pneumonia Risk Among Viral Acute Respiratory Distress Syndrome Related or Not to COVID 19"
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Cattaneo L, Buonomo A, Iacovazzo C, Giaccone A, Scotto R, Viceconte G J Fungi (Basel). 2023; 9(1).
PMID: 36675909 PMC: 9865967. DOI: 10.3390/jof9010086.
References
1.
Yale S, Limper A
. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996; 71(1):5-13.
DOI: 10.4065/71.1.5.
View
2.
Razazi K, Arrestier R, Haudebourg A, Botterel F, Mekontso Dessap A
. Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19. Crit Care. 2021; 25(1):348.
PMC: 8474854.
DOI: 10.1186/s13054-021-03767-3.
View
3.
Del Corpo O, Butler-Laporte G, Sheppard D, Cheng M, McDonald E, Lee T
. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clin Microbiol Infect. 2020; 26(9):1137-1143.
DOI: 10.1016/j.cmi.2020.05.024.
View
4.
Viceconte G, Buonomo A, Lanzardo A, Pinchera B, Zappulo E, Scotto R
. pneumonia in an immunocompetent patient recovered from COVID-19. Infect Dis (Lond). 2021; 53(5):382-385.
DOI: 10.1080/23744235.2021.1890331.
View
5.
De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T
. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group.... Clin Infect Dis. 2008; 46(12):1813-21.
PMC: 2671227.
DOI: 10.1086/588660.
View